SEC Form 4 · accession 0001288123-16-000096
AGENUS INC · AGEN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Garo H Armen
Officer — Chairman & CEO
Period of report
Dec 21, 2016
Accepted (ET)
Dec 23, 2016 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001098972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 21, 2016 | J | 78,001 | $4.19 | D | 1,470,882 | D | |
| Common Stock | Dec 22, 2016 | J | 152,405 | $4.06 | D | 1,318,477 | D | |
| Common StockF2 | holding | — | — | — | 4,046 | I | By Antigenics Holdings |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares donated to a charitable organization.
- F2Dr. Armen is Chairman of the Board of Managers and a member of Antigenics Holdings LLC ("Holdings") which as of the date of this report owns 4,046 shares of Agenus Inc. common stock. Dr. Armen has a pecuniary interest inonly a portion of the shares held by Holdings and disclaims beneficial ownership to the extent of his pecuniary interest therein.